Igene Biotechnology EPS
Earnings per Share (EPS) of Igene Biotechnology (IGNE) as of Oct 31, 2026.
Get this data via API
Financial Data API
EPS
-0.00USD
Last updated:
Earnings per Share (EPS) of Igene Biotechnology is 2009 -0.00 USD. Earnings per Share (EPS) of Igene Biotechnology was 2008 - USD. It decreases by % lower compared to the previous year.
The Igene Biotechnology EPS history
3 Years
10 Years
25 Years
Max
EPS
Date
EPS
Jan 1, 2000
-0.04 USD
Jan 1, 2001
-0.05 USD
Jan 1, 2002
-0.04 USD
Jan 1, 2003
-0.02 USD
Jan 1, 2006
-0.01 USD
Jan 1, 2007
-0.02 USD
Jan 1, 2008
-0.00 USD
Jan 1, 2009
-0.00 USD
| YEAR | EPS | YoY |
|---|---|---|
| -0.00USD | -98.06% | |
| -0.00USD | -72.89% | |
| -0.02USD | +61.85% | |
| -0.01USD | -55.21% | |
| -0.02USD | -37.27% | |
| -0.04USD | -21.61% | |
| -0.05USD | +27.23% | |
| -0.04USD | +2,259.38% | |
| -0.00USD | -98.67% | |
| -0.12USD | +20.76% | |
| -0.10USD | +138.84% | |
| -0.04USD | +14.82% | |
| -0.04USD | -12.07% | |
| -0.04USD | -25.29% | |
| -0.06USD | -40.93% | |
| -0.09USD | -61.40% | |
| -0.24USD | -73.70% | |
| -0.93USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Igene Biotechnology Stock analysis
What does Igene Biotechnology do? Igene Biotechnology Inc is a global biotechnology company focused on researching, developing, and marketing innovative solutions in the fields of health, nutrition, and the environment. The company was founded in Taipei, Taiwan, in 2005 and has since built an impressive track record of scientifically-based products and services.
The business model of Igene Biotechnology Inc is based on the belief that advanced biotechnological technologies are the key to addressing the complex challenges facing humanity in terms of health, nutrition, and the environment. The company has specialized expertise in genomic research, microbial cultivation, fermentation, biochemistry, and nanotechnology, on which advanced products and services are built.
Igene Biotechnology Inc is divided into three business divisions, each operating in different markets: healthcare, disease prevention, and environmental solutions. Each business division offers a wide range of products and services tailored to the specific needs of these markets.
In the healthcare sector, Igene Biotechnology Inc focuses on developing innovative dietary supplements and functional foods designed to maintain and improve health. The company has developed a wide range of products tailored to the different needs of people, from vitamins and minerals to probiotic supplements and high-quality omega-3 fatty acid preparations. All products are scientifically-based and manufactured under strict quality controls.
In the field of disease prevention, Igene Biotechnology Inc also offers a wide range of products and services. This involves meeting the specific needs of people with various diseases. The company offers diagnostic services, among other things, to meet the demand for personalized medicine. Igene Biotechnology Inc also develops special dietary supplements and medications for the treatment of chronic diseases such as diabetes, arthritis, and cardiovascular diseases.
In the field of environmental solutions, Igene Biotechnology Inc focuses on developing innovative technologies and products to solve environmental problems. The company uses its extensive knowledge in the areas of microorganisms, fermentation, and bioreactors to offer diverse solutions, from wastewater treatment to the production of bioenergy and biobased chemicals.
Over the years, Igene Biotechnology Inc has developed a large number of products that have been successfully introduced worldwide. The product range includes dietary supplements, functional foods, diagnostic and therapeutic devices, as well as environmentally friendly chemicals and biofuels. The focus on customer needs and close collaboration with scientific and industrial partners have helped make Igene Biotechnology Inc a globally recognized and respected company.
Overall, Igene Biotechnology Inc has established itself as a leading company in the field of biotechnological innovations. The company has achieved impressive success in recent years and continues to strive to develop innovative solutions and services that contribute to health, nutrition, and the environment. Igene Biotechnology is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Igene Biotechnology stock
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Igene Biotechnology since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Igene Biotechnology
All Key Metrics — Igene Biotechnology
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth